Integrated BioPharma, Inc. (INBP)
OTCMKTS · Delayed Price · Currency is USD
0.1603
+0.00961 (6.38%)
At close: Aug 7, 2026
Integrated BioPharma Market Cap
Integrated BioPharma has a market cap or net worth of $4.98 million as of August 10, 2026. Its market cap has decreased by -40.63% in one year.
Market Cap
4.98M
Enterprise Value
2.50M
Revenue
48.25M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.16
ChartMarket Cap Chart
Since December 22, 1995, Integrated BioPharma's market cap has decreased from 25.02M to 4.98M, a decrease of -80.10%. That is a compound annual growth rate of -5.13%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2026 | 4.98M | -54.85% |
| Dec 31, 2025 | 11.03M | 10.37% |
| Dec 27, 2024 | 9.99M | 35.38% |
| Dec 29, 2023 | 7.38M | -29.98% |
| Dec 30, 2022 | 10.54M | -66.03% |
| Dec 29, 2021 | 31.03M | 41.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Glucose Health | 8.91M |
| Next Meats Holdings | 7.83M |
| Steakholder Foods | 7.81M |
| NutraProducts | 7.20M |
| Strake | 6.74M |
| SkyTech Orion Global | 6.24M |
| BAB, Inc. | 6.14M |
| GPO Plus | 3.66M |